Problems of multidrug- and extensively drug-resistant TB

Drug and Therapeutics Bulletin

Volumn 50, Issue 2, 2012, Pages 21-24

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN;

ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; DISEASE COURSE; HUMAN; INFECTION CONTROL; INFECTION RISK; LUNG RESECTION; LUNG TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; RISK ASSESSMENT; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TREATMENT DURATION;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84857136100     PISSN: 00126543     EISSN: 17555248     Source Type: Journal    
DOI: 10.1136/dtb.2012.02.0087     Document Type: Article

References (24)

1. World Health Organization, 2011. Global tuberculosis control 2011 [online]. Available: http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf [Accessed 19 January 2012].
2. World Health Organization, 2010. Treatment of Tuberculosis: Guidelines, 4th ed [online]. Available: http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf [Accessed 19 January 2012].
3. National Institute for Health and Clinical Excellence, 2011. Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Clinical guidance 117 [online]. Available: http://www.nice.org.uk/guidance/index.jsp?action=byID&o=13422 [Accessed 19 January 2012].
4. Ma Z et al. Global tuberculosis drug development pipeline: the need and the reality. Lancet 2010; 375: 2100-9.
5. Gandhi NR et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375: 1830-43.
6. World Health Organization, 2008. Anti-tuberculosis drug resistance in the world report number 4 [online]. Available: http://whqlibdoc.who.int/hq/2008/who_ htm_tb_2008.394_eng.pdf [Accessed 19 January 2012].
7. Abubakar I et al. Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. Thorax 2009; 64: 512-5.
8. Lönnroth K et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010; 375: 1814-29.
9. Wallis RS et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010; 375: 1920-37.
10. World Health Organization, 2012. Tuberculosis profile United Kingdom of Great Britain and Northern Ireland [online]. Available: http://www.who.int/tb/country/data/profiles/en/index.html [Accessed 19 January 2012].
11. World Health Organization, 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 global report on surveillance and response [online]. Available: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf [Accessed 19 January 2012].
12. Clinical Knowledge Summaries. Tuberculosis (including people with HIV) assessment & referral - Management. online. Available: http://www.cks.nhs.uk/tuberculosis/management/scenario_diagnosis/view_full_scenario [Accessed 19 January 2012].
13. Department of Health. Tuberculosis Green Book, 2011. [online]. Available: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_128356.pdf [Accessed 19 January 2012].
14. Cheng VCC et al. Molecular diagnostics in tuberculosis. Eur J Clin Microbiol Infect Dis 2005; 24: 711-20.
15. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 2000; 55: 887-901.
16. Medical Letter. Drugs for tuberculosis. Medical Letter 2009; 7: 75-82.
17. Ma B et al. Diagnostic test of rifampicin resistance in mycobacterium tuberculosis: a meta-analysis. J Evid Based Med 2011; 4: 15-21. M
18. Chang KC et al. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analysis. Antimicrobial Agents and Chemotherapy 2011; 55: 4499-4505.
19. Marais BJ et al. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010; 375: 2179-91.
20. World Health Organization, 2011. Guidelines for the Programmatic Management of Drug Resistant Tuberculosis 2011 update [online] Available: http://whqlibdoc.who.int/publications/2011/9789241501583_eng.pdf [Accessed 19 January 2011].
21. Raviglione MC et al. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-5.
22. Pozniac AL et al. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011. HIV Med 2011; 12: 517-24.
23. Xu HB et al. Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. J Antimicrob Chemother 2011; 66: 1687-95.
24. Raviglione MC. The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015. Bull World Health Organ 2007; 85: 327.